• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Commentary: Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy.

作者信息

Skolnik Aaron D, Wang Sumei, Gopal Pallavi P, Mohan Suyash

机构信息

Radiology, Penn Medicine Princeton Health, Plainsboro, NJ, United States.

Neuroradiology, Hospital of the University of Pennsylvania, Philadelphia, PA, United States.

出版信息

Front Neurol. 2018 Feb 5;9:51. doi: 10.3389/fneur.2018.00051. eCollection 2018.

DOI:10.3389/fneur.2018.00051
PMID:29459848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5807681/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6acb/5807681/9f2082c8437d/fneur-09-00051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6acb/5807681/9f2082c8437d/fneur-09-00051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6acb/5807681/9f2082c8437d/fneur-09-00051-g001.jpg

相似文献

1
Commentary: Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy.评论：抗血管生成及免疫/靶向治疗时代胶质母细胞瘤神经影像学的陷阱
Front Neurol. 2018 Feb 5;9:51. doi: 10.3389/fneur.2018.00051. eCollection 2018.
2
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.抗血管生成和免疫/靶向治疗时代胶质母细胞瘤的神经影像学陷阱 - 检测虚幻的疾病，定义反应。
Front Neurol. 2015 Feb 23;6:33. doi: 10.3389/fneur.2015.00033. eCollection 2015.
3
Radiological features of infantile glioblastoma and desmoplastic infantile tumors: British Columbia's Children's Hospital experience.婴儿型胶质母细胞瘤和促纤维增生性婴儿型肿瘤的放射学特征：不列颠哥伦比亚儿童医院的经验
J Neurosurg Pediatr. 2015 Aug;16(2):119-25. doi: 10.3171/2014.10.PEDS13634. Epub 2015 May 8.
4
Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.IVIM-DWI与3D-ASL联合用于鉴别多形性胶质母细胞瘤同步放化疗后真性进展与假性进展：一项前瞻性诊断试验的研究方案
BMC Med Imaging. 2017 Feb 1;17(1):10. doi: 10.1186/s12880-017-0183-y.
5
Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.胶质母细胞瘤患者磁共振成像特征与 miRNA 基因表达的关系。
Chin Med J (Engl). 2013;126(15):2881-5.
6
Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy-Detecting Elusive Disease, Defining Response.社论：抗血管生成和免疫靶向治疗时代胶质母细胞瘤神经影像学的陷阱——检测隐匿性疾病、定义反应
Front Neurol. 2017 Jul 3;8:311. doi: 10.3389/fneur.2017.00311. eCollection 2017.
7
Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.174 例多形性胶质母细胞瘤患者中， upfront boost Gamma Knife“前沿”放射外科治疗 FLAIR MRI 定义的肿瘤迁移途径：15 年新型治疗方法评估。
J Neurosurg. 2016 Dec;125(Suppl 1):40-49. doi: 10.3171/2016.7.GKS161460.
8
Quantification of serial changes in cerebral blood volume and metabolism in patients with recurrent glioblastoma undergoing antiangiogenic therapy.复发性胶质母细胞瘤患者接受抗血管生成治疗时脑血容量和代谢的系列变化定量分析。
Eur J Radiol. 2015 Jun;84(6):1128-36. doi: 10.1016/j.ejrad.2015.02.025. Epub 2015 Mar 6.
9
Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma.靶向 APLN/APLNR 可提高抗血管生成效率，并减轻 VEGFA/VEGFR2 阻断在胶质母细胞瘤中的促侵袭副作用。
Cancer Res. 2019 May 1;79(9):2298-2313. doi: 10.1158/0008-5472.CAN-18-0881. Epub 2019 Feb 4.
10
Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme.用于多形性胶质母细胞瘤的磁共振纳米诊疗技术
Curr Pharm Des. 2015;21(36):5256-66. doi: 10.2174/1381612821666150923103307.

引用本文的文献

1
Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma.代谢和生理磁共振成像在鉴别胶质母细胞瘤患者真性进展与假性进展中的作用。
NMR Biomed. 2022 Jul;35(7):e4719. doi: 10.1002/nbm.4719. Epub 2022 Mar 15.
2
Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing.与传统图像采集时间相比，延迟氟代脱氧葡萄糖正电子发射断层扫描（FDG PET）对胶质母细胞瘤的显示效果更佳。
Front Neurol. 2021 Nov 16;12:740280. doi: 10.3389/fneur.2021.740280. eCollection 2021.
3
Emerging Applications of Artificial Intelligence in Neuro-Oncology.

本文引用的文献

1
Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.采用先进的磁共振成像评估预测复发性胶质母细胞瘤患者抗程序性细胞死亡蛋白1免疫治疗反应的获益情况。
Neuroradiology. 2017 Feb;59(2):135-145. doi: 10.1007/s00234-016-1769-8. Epub 2017 Jan 9.
2
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.嵌合抗原受体T细胞疗法后胶质母细胞瘤的消退
N Engl J Med. 2016 Dec 29;375(26):2561-9. doi: 10.1056/NEJMoa1610497.
3
Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
人工智能在神经肿瘤学中的新兴应用。
Radiology. 2019 Mar;290(3):607-618. doi: 10.1148/radiol.2018181928. Epub 2019 Jan 22.
4
Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma.多参数磁共振成像在评估抗 EGFRvIII 嵌合抗原受体 T 细胞疗法治疗复发性胶质母细胞瘤患者中的应用。
Br J Cancer. 2019 Jan;120(1):54-56. doi: 10.1038/s41416-018-0342-0. Epub 2018 Nov 27.
多形性胶质母细胞瘤患者实验性靶向治疗和免疫治疗的进展
Anticancer Res. 2017 Jan;37(1):21-33. doi: 10.21873/anticanres.11285.
4
Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study.计算机提取纹理特征在多参数磁共振成像上区分脑放射性坏死与复发性脑肿瘤的可行性研究
AJNR Am J Neuroradiol. 2016 Dec;37(12):2231-2236. doi: 10.3174/ajnr.A4931. Epub 2016 Sep 15.
5
Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma.贝伐单抗诱导的进行性扩散受限与复发性胶质母细胞瘤患者中被存活肿瘤包围的凝固性坏死及总生存期缩短有关。
AJNR Am J Neuroradiol. 2016 Dec;37(12):2201-2208. doi: 10.3174/ajnr.A4898. Epub 2016 Aug 4.
6
The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma.贝伐单抗治疗后扩散降低的发展可识别高级别胶质瘤患者的复发疾病区域。
Acad Radiol. 2016 Sep;23(9):1073-82. doi: 10.1016/j.acra.2016.04.004. Epub 2016 Jul 18.
7
Assessment of early response to tumor-treating fields in newly diagnosed glioblastoma using physiologic and metabolic MRI: initial experience.使用生理和代谢磁共振成像评估新诊断胶质母细胞瘤对肿瘤治疗电场的早期反应：初步经验
CNS Oncol. 2016 Jul;5(3):137-44. doi: 10.2217/cns-2016-0003. Epub 2016 Apr 14.
8
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets.胶质瘤干细胞及其微环境：具有挑战性的治疗靶点来源
Stem Cells Int. 2016;2016:5728438. doi: 10.1155/2016/5728438. Epub 2016 Feb 10.
9
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.替莫唑胺联合肿瘤电场治疗与替莫唑胺单药治疗胶质母细胞瘤的维持治疗：一项随机临床试验。
JAMA. 2015 Dec 15;314(23):2535-43. doi: 10.1001/jama.2015.16669.
10
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.神经肿瘤学中的免疫治疗反应评估：RANO工作组报告
Lancet Oncol. 2015 Nov;16(15):e534-e542. doi: 10.1016/S1470-2045(15)00088-1.